Smart Peptide Defense Web In Situ Connects for Continuous Interception of IgE against Allergic Rhinitis.

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Allergic rhinitis (AR) is a prevalent chronic condition affecting 10-40% of the global population, significantly reducing quality of life.
• Persistent AR can lead to severe health issues, including asthma, due to chronic inflammation.
• Current treatments may not offer long-term relief and can have side effects.

Purpose of the Study:

• To develop and evaluate a novel Smart Peptide Defense (SPIN) web technique for trapping immunoglobulin E (IgE) in situ.
• To assess the therapeutic efficacy of two candidate SPINs (SPIN-1 and SPIN-2) in an AR mouse model.
• To compare the long-term therapeutic effects of SPINs with a first-line clinical drug, cetirizine.

Main Methods:

• Design of two candidate SPINs (SPIN-1, SPIN-2) with specific IgE-binding sequences.
• In situ construction of a peptide web from nanoparticles upon IgE binding.
• Administration of SPIN-1 or SPIN-2 (10 mg/kg) to AR model Balb/c mice and assessment of rhinitis symptoms and inflammatory factors.
• Measurement of IL-4 levels as a key inflammatory marker.

Main Results:

• SPIN-1 and SPIN-2 successfully transformed from nanoparticles into entangled nanofibers, forming a web that trapped IgE.
• Both SPIN-1 and SPIN-2 significantly reduced rhinitis symptoms and inflammatory factors in AR mice.
• SPINs demonstrated superior long-term therapeutic effects (1 week) compared to cetirizine (1 day), with notable reduction in IL-4 levels.

Conclusions:

• The SPIN web technique effectively blocks IgE binding to mast cells in vivo.
• SPINs show great potential as a long-term therapeutic strategy for allergic rhinitis and other IgE-mediated allergic reactions.
• This innovative approach offers a promising alternative to existing treatments for allergic diseases.